These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4057424)

  • 1. The effect of nitrofurantoin on bladder tumor cell lines: in vitro growth and implantation in the cauterized mouse bladder.
    Bulbul MA; Chin JL; Huben RP; Englander LS; Pontes JE
    J Urol; 1985 Dec; 134(6):1231-5. PubMed ID: 4057424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS; Slocum HK; Rustum YM; Greco WR; Gaeta JF; Huben RP
    J Urol; 1989 Dec; 142(6):1589-93. PubMed ID: 2511340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat bladder isograft model for focal carcinoma.
    Mei H; Hagen IK; Allhoff EP; Lin JC; Chapman CM; Proppe KH; Prout GR; Lin CW
    J Urol; 1982 Sep; 128(3):629-32. PubMed ID: 7120581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of urothelium to neoplastic cellular implantation.
    Weldon TE; Soloway MS
    Urology; 1975 Jun; 5(6):824-7. PubMed ID: 1136099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinyl acetate prophylaxis in cancer of the urinary bladder.
    Dawson WD; Miller WW; Liles WB
    Invest Urol; 1979 Mar; 16(5):376-7. PubMed ID: 429134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate inhibition of tumor cell implantation in the murine urinary bladder.
    Van Every MJ; Sago AL; Ehler WJ; Novicki DE
    J Urol; 1988 Jul; 140(1):188-90. PubMed ID: 3379686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial susceptibility to tumor cell implantation: comparison of cauterization with N-methyl-N-nitrosourea.
    Soloway MS; Nissenkorn I; McCallum L
    Urology; 1983 Feb; 21(2):159-61. PubMed ID: 6337445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of ascorbic acid to inhibit FANFT-induced bladder cancer.
    Soloway MS; Cohen SM; Dekernion JB; Persky L
    J Urol; 1975 Apr; 113(4):483-6. PubMed ID: 1117519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed.
    Khandaker MH; Kadhim SA; Ichim TE; Howson-Jan K; Chin J; Singhal SK
    Anticancer Res; 2000; 20(1A):183-9. PubMed ID: 10769653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model for bladder cancer.
    Murphy GP; Sandberg AA; Pontes JE; Ochi H; Yoshida M; Williams PD
    Prog Clin Biol Res; 1984; 162A():177-200. PubMed ID: 6541340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.
    Sindhwani P; Hampton JA; Baig MM; Keck R; Selman SH
    J Urol; 2001 Oct; 166(4):1498-501. PubMed ID: 11547120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine.
    Borden EC; Sidky YA; Ertürk E; Wierenga W; Bryan GT
    Cancer Res; 1990 Feb; 50(4):1071-4. PubMed ID: 2297754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of bladder cancer.
    Friedell GH; Jacobs JB; Nagy GK; Cohen SM
    Am J Pathol; 1977 Nov; 89(2):431-42. PubMed ID: 920778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of murine bladder cancer by irradiated tumor vaccine.
    Lamm DL; Riggs DR; DeHaven JI; Bryner RW
    J Urol; 1991 Jan; 145(1):195-8. PubMed ID: 1984090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic characteristics of four FANFT-induced murine bladder tumors.
    Crabtree WN; Soloway MS; Matheny RB; Murphy WM
    Urology; 1983 Nov; 22(5):529-31. PubMed ID: 6649210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors.
    Mickey DD; Mickey GH; Murphy WM; Niell HB; Soloway MS
    J Urol; 1982 Jun; 127(6):1233-7. PubMed ID: 7087044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
    Soloway MS; Martino C; Hyatt C; Marrone JC
    Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of a transplantable dibutylnitrosamine-induced mouse bladder tumor line FCB.
    Flaks A; Flaks B
    Cancer Res; 1973 Dec; 33(12):3285-92. PubMed ID: 4760540
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship of histamine H2 receptor-bearing suppressor cells with the growth and metastasis of FANFT-induced bladder cancer.
    Babayan RK; Osband ME; Carpinito GA; Ho ZS; Cohen EB; Krane RJ
    J Surg Oncol; 1983 Sep; 24(1):53-8. PubMed ID: 6224980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.